October 03, 2018
Rose
Memorial Sloan Kettering Cancer Center President, Dr. Craig Thompson, announced that he will resign from the boards of Merck and Charles River Laboratories. Merck is the maker of the blockbuster cancer treatment Keytruda. Memorial Sloan Kettering Cancer Center has been thrust under the microscope recently over controversy involving top officials' financial conflicts of interest.
from Kaiser Health News https://ift.tt/2y9Z43a
October 03, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
The Solution to Au Pairs’ Health Coverage Gaps May Be Simple: ACA Plans- Congress Cites KHN Investigation in Probe of National Academies
- At an Overrun ICU, ‘the Problem Is We Are Running Out of Hallways’
- California’s Reboot of Troubled Medi-Cal Puts Pressure on Health Plans
- ‘An Arm and a Leg’: They Turned Grief Into Action
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment